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Research in pathologies of the brain, heart and kidney have gained immensely from the
plethora of studies that have helped shape new methods in magnetic resonance (MR)
for characterizing preclinical disease models. Methodical probing into preclinical animal
models by MR is invaluable since it allows a careful interpretation and extrapolation of
data derived from these models to human disease. In this review we will focus on the
applications of cryogenic radiofrequency (RF) coils in small animal MR as a means of
boosting image quality (e.g., by supporting MR microscopy) and making data acquisition
more efficient (e.g., by reducing measuring time); both being important constituents for
thorough investigational studies on animal models of disease. This review attempts to
make the (bio)medical imaging, molecular medicine, and pharmaceutical communities
aware of this productive ferment and its outstanding significance for anatomical and
functional MR in small rodents. The goal is to inspire a more intense interdisciplinary
collaboration across the fields to further advance and progress non-invasive MRmethods
that ultimately support thorough (patho)physiological characterization of animal disease
models. In this review, current and potential future applications for the RF coil technology
in cardiovascular, neurovascular, and renal disease will be discussed.
Keywords: magnetic resonance, MRI, cardiovascular imaging, neurovascular imaging; renal imaging, MR
technology, radio frequency coils, cryogenic
INTRODUCTION
For several decades animal models have served a wide span of applications in the life sciences.
Transgenic systems have been invaluable for studying molecular signatures and specific cell
populations as well as tools for non-invasive reporter gene imaging. Animal models that simulate
human pathologies have also been indispensable for uncoveringmechanisms behindmajor diseases
as well as the identification of their respective treatments.
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A thorough characterization of each animal model remains
the crux of the matter. It ensures that the right conclusions are
drawn from preclinical studies dealing with questions around
pathogenesis and therapy as well as molecular studies that set the
groundwork for future therapies and drug design. It is getting
increasingly clear that most conditions and diseases, even those
with an underlying genetic component, are multi-factorial and
complex in nature suggesting that therapy should be equally
intricate and versatile. It has been suggested that partial, but
multiple, drug actions might be more efficient than a complete
drug action at a single target in complex multifactorial disease.
This calls for novel drug-design strategies that will depend
not only on computational modeling for identifying correct
multiple targets but also importantly on more-efficient and high-
throughput in vivo testing. Further developments in non-invasive
in vivo imaging in small rodents are necessary to guarantee this,
as well as a swift and robust translation into clinical practice. For
this to be achieved there is an absolute need for (i) anatomical and
function imaging with a superb spatial and temporal resolution,
(ii) high reproducibility in results, and (iii) longitudinal studies
with sufficient statistical power.
Preclinical Magnetic Resonance Imaging (MRI) is
conceptually appealing in the pursuit of basic and translational
research as well as for explorations into cardiovascular,
neurovascular, and renal disease. MRI has become increasingly
important for small animal imaging at multiple levels of pre-
clinical research. A growing number of reports manifest the
advances for morphological and functional MRI of the heart,
large blood vessels, CNS, and kidney. Notwithstanding its success
and ubiquity, the relatively low sensitivity of conventional MRI
constitutes an impediment for translational research and pre-
clinical applications. Constraints common to standard room
temperature RF MR detectors include contrast-to-noise-ratio
(CNR) and spatial resolution but also acquisition time and
signal-to-noise ratio (SNR), which are particular currencies
spent for image quality.
In recent years, cryogenic RF coil technology that provides
significant improvements in image quality has been made
commercially available to small animal researchers. The
cryogenic technology substantially increases SNR over standard
room temperature RF-coils by considerably reducing thermal
noise and signal losses in the RF receiver electronics. This
facilitates the acquisition of high spatial resolution images within
shorter scan times. The gain in SNR via cryogenic-cooling
corresponds to the gain achieved by an equivalent increase in
magnetic field strength, but without the extra challenges and
costs—which could be prohibitive at extreme ultrahigh magnetic
fields.
Recognizing the technical advancement in cryogenic RF
coil technology this review attempts to make the (bio)medical
imaging, molecular medicine, and pharmaceutical communities
aware of this productive ferment and its outstanding significance
for anatomical and functional MR in small rodents. The goal
is to inspire collaborations across disciplinary boundaries and
to attract basic scientists, translational researchers, clinician
scientists, and new entrants into the field to advance the
capabilities of non-invasive MR imaging through the RF coil
technology. In the sections that follow some of the potential
applications for cryogenic RF coil technology are discussed.
Neurovascular applications for cryogenic RF coil technology
include morphological imaging and functional brain mapping in
mice. The benefits of cryogenically-cooled RF coils in supporting
MRI microscopy (defined by a spatial resolution <100µm) in
vivo are demonstrated; the morphological detail reveals brain
pathology in animal models of neuroinflammatory diseases,
which opens the opportunity to follow neuroinflammatory
processes even during the early stages of disease progression.
Examples of MR angiography are presented, especially within
the context of neurovascular disease. Early and frontier
applications of cryogenic RF coil technology in cardiovascular
MRI are surveyed together with the opportunities for high
spatial resolution cardiac chamber quantification and parametric
mapping; all being facilitated by the traits of cryogenic RF coil
technology. Last but not least, the sensitivity gain of cryogenic RF
coil technology is put to good use for renal MR microscopy and
in vivoMRI to support explorations into renal diseases with non-
invasive techniques for probing renal perfusion, hypoxia and
inflammation. A concluding section ventures a glance beyond
the horizon and explores future directions. Of course, MRI of
small rodents is an area of vigorous ongoing research, and many
potentially valuable developments will receive only brief mention
here.
TECHNICAL CONSIDERATIONS
State of the Art
To date, cryogenic RF coils have been developed by making
use of either copper or high-temperature superconducting
(HTS) material. In this review we limit ourselves primarily to
copper cryogenic coils (CryoProbe, Bruker Biospin, Erlangen,
Germany) since these are available to a broader spectrum of
users. Pioneering HTS coils have been developed by specialized
research groups and are not commercially available yet. Although
complex to operate, these coils can achieve SNR gains of more
than 10-fold as demonstrated in small excised samples at high
field (Black et al., 1993) or in the living mouse at 1.5 T (Poirier-
Quinot et al., 2008).
Image Quality and Signal-to-noise Ratio
Image quality describes the perceived or quantitatively
measured degradation of an image in comparison to its
“perfect” counterpart. In MRI this translates into how well the
reconstructed image represents the characteristics of the RF
signals originating from the excited MR nuclei. Image contrasts
are the core information in the majority of MRI applications.
Contrasts allow the delineation of morphological structures
and pathological lesions (spatial contrast) or the detection of
signal intensity changes over time in functional MRI (temporal
contrast). Detrimental factors for MR image quality include
artifacts and noise.
The SNR is a quantitative metric of image quality with regards
to noise. From an MR image SNR is commonly calculated by
dividing the mean signal intensity of a uniform region of interest
covering the target region by the standard deviation of the
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noise commonly derived from the background free of signal
or artifacts. While high SNRs (>100) allow high confidence
in the MR data, low SNRs (<20) mean that the true image
characteristics are increasingly masked by noise.
The SNR dependence on MR protocol parameters for a
conventional 2D experiment is (McRobbie et al., 2006):
SNR ∝ FOVFE · FOVPE · △z · Fsequence ·
√
NA√
BW · NFE · NPE
(1)
where FOV is the field-of-view in frequency encoding (FE)
and phase encoding (PE) direction, 1z is the slice thickness,
Fsequence is the appropriate sequence dependent factor [including
repetition time TR and echo time TE in relation to the relaxation
times T1 and T
(∗)
2 ], NA is the number of signal averages, BW is
the receiver bandwidth across the image and N is the acquisition
matrix size in FE and PE direction. In practice, temporal signal
averaging is the most commonly used approach to balance
the competing needs for high spatial resolution, high spatial
coverage, temporal resolution, and sufficient signal to noise. Yet,
signal averaging comes at the cost of scan time when using
standard gradient echo or spin echo imaging techniques, without
the implementation of acceleration techniques such as parallel
imaging or compressed sensing. The square root relation of SNR
with the number of averages very quickly sets a limit at which
more averages can no longer be justified with a substantial SNR
gain due to the severe scan time penalty governed by the power
of 2 of the number of averages.
Why Cooling the Radiofrequency Hardware
Improves Image Quality
SNR of an MR image is closely linked to the quality of
the acquired RF signals it is composed of. These RF signal
measurements—like all analog electronic measurements—are
degraded by noise, which reduces signal quality and hence image
quality. RF coil efficiency relies on overcoming thermal noise
induced by conductive samples (Hoult and Lauterbur, 1979).
The noise in MR signal acquisitions originates predominantly
from thermal (Brownian) motion of electrical charge carriers
within the passive receiver electronics (e.g., coil, conductors,
passive components) and within the sample itself. Particularly
susceptible to noise are those parts of the electronics in which
the RF signal is very small, i.e., from the RF coil until the
preamplifier output. The contribution of a 50Ohm preamplifier
to the noise cannot be so easily described because of the reactive
part of its impedance, though it can be evaluated by acquiring and
comparing noise images at different temperatures e.g., at 77 and
293K (Poirier-Quinot et al., 2008; Vaughan and Griffiths, 2012).
The concept of cooling RF coil hardware to reduce thermal
noise was originally proposed in the 1970s by D. I. Hoult
and R. E. Richards (Hoult and Richards, 1976), although the
first actual application of cooled RF coils in room-temperature
samples was introduced nearly a decade later (Styles et al., 1984).
The temperature dependency of the SNR can be described with
(Kovacs et al., 2005; Junge, 2012):
SNR ∝ ω0B1√
RSTS+RCTC+(RS+RC)TA
(2)
where ω0 is the Larmor angular frequency, B1 is the effective
RF field in the sample volume, RS represents the so-called
magnetic and electric loss in the sample (sample resistance),
RC is the resistive loss in the RF coil and TS/C/A is the
temperature of the sample, coil, and the noise temperature of the
preamplifier, respectively. Cooling reduces the coil noise RCTC
and preamplifier noise (RS+ RC)TA and directly increases SNR.
An additional benefit of cooling the receiver electronics is owed
to the decrease of electrical resistances in the conductor (RC) with
decreasing temperatures. Reducing losses within the RF receive
chain enhances the SNR.
However, SNR is also dependent on other factors such as
frequencyω0, RF coil geometry/quality (creating the effective B1)
and sample noise RSTS. Comparing the impacts of coil noise and
sample noise on SNR in the context of RF coil size helps to answer
the question whether—and under which circumstances—cooling
the RF coil is worthwhile. As shown by Junge (2012), the coil and
sample noise contributions to SNR at room temperature are of
comparable magnitude for a single loop coil with a diameter of
approximately 3.0 cm (at 1.5 T) or 1.4 cm (at 9.4 T). For larger
RF coils sizes, as commonly used in human MRI, sample noise
contributions dominate SNR. For small animal MRI the volumes
of interest and RF coil sizes are typically in the range of 1–2 cm,
rendering coil noise contributions comparable or larger than
sample noise contributions. Although cooling the RF hardware
will always reduce noise, the engineering and cost of cryogenic
RF hardware starts to pay off only when the thermal noise
originating from the receiver electronics is comparable or larger
than the noise originating from the sample (patient, animal,
object under investigation). It is for that reason that cryogenic
RF coils have been developed primarily for nuclear magnetic
resonance spectroscopy (NMR; see review Kovacs et al., 2005)
using small samples of few millimeter diameter or few cubic-
millimeter volume and more recently for small animal MRI.
The theoretical upper limit for the SNR improvement at a
magnetic field strength of 9.4 T (f = 400MHz) is an estimated
factor of 2.8 for a transmission line resonator consisting of
two planar split rings (with an inner diameter of 14mm) that
are placed on either side of a dielectric substrate, under the
assumption of cooling the RF coil from room temperature down
to 0K (Junge, 2012). Cooling the preamplifier has a similar effect
on SNR for small samples (Kovacs et al., 2005), but taking a
typical preamplifier noise temperature of 15K with a dominating
sample noise (RS >> RC) at 310K, the SNR equation shows that
the noise contribution from the preamplifier is not that critical.
In practice however the SNR gain achievable by a cryogenic RF
coil is lower than the theoretical estimate. The RF hardware
cannot be cooled down to 0 K. RF coil and preamplifier are
typically operated at temperatures around −253◦C (20K) and
−193◦C (80K), respectively. Notwithstanding these limitations,
an SNR gain as high as 2.5 was reported for in vivo mouse
brain MRI when comparing cryogenic RF hardware (400MHz
CryoProbe, Bruker Biospin MRI GmbH, Ettlingen, Germany)
with a conventional room temperature RF coil setup of similar
geometry (Baltes et al., 2009).
According to Hoult and Lauterbur (1979), sample resistance
RS increases quadratically with the Lamor frequency ω0 for
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a well-designed RF coil. Thus, it may counterbalance the
upper frequency term in the above Equation (2) toward higher
frequencies. Higher SNR gains are expected at frequencies lower
than 400MHz and have been indeed reported at 200MHz
using the same cooled copper coil technology (Ratering et al.,
2008). The gain becomes even higher when using the HTS coil
technology at lower frequencies (Darrasse and Ginefri, 2003):
SNR gains larger than 10-fold were achieved at 64MHz in
the living mouse brain (Poirier-Quinot et al., 2008). Thus, the
cryogenic technology will be particularly valuable for preclinical
studies when used in combination with clinical field strengths.
Cryogenic Radiofrequency Coil Hardware
The first commercial cryogenically cooled RF probe for NMR
spectroscopy was installed in 1999 (Kovacs et al., 2005). It
took almost 10 years for this technology to mature and to
become commercially available for small animal MR scanners.
The feasibility and benefit of cryogenically-cooledMRI RF probes
was demonstrated for in vivomouse brain imaging at 9.4 T (Baltes
et al., 2009). This success built upon the pioneering explorations
into cryogenic RF coil designs for biomedical MRI by researches
such as Hurlston et al. (1999), Ginefri et al. (2007), Nouls et al.
(2008) and the successful development of a prototype for 4.7 T
(Ratering et al., 2008).
Modern cryogenic RF hardware employs high temperature
superconducting (HTS) materials to dramatically reduce resistive
losses (Black et al., 1993; Hurlston et al., 1999; Darrasse and
Ginefri, 2003; Ginefri et al., 2007; Nouls et al., 2008; Junge,
2012; not commercially available yet). Cold helium gas has
replaced liquid cryogens as cooling media. Simply speaking,
Helium gas is compressed in one chamber and then chilled
through expansion in another chamber in a closed-loop cooling
system—comprised of the RF coil, a cryogenic cooling unit and
a helium compressor. The waste heat produced during the gas
compression is transferred from the helium compressor to a cold
water system via a connected water chiller.
For a review of cryogenically cooled RF coil hardware, we
will focus here on the range of commercially available cryogenic
RF surface coils for preclinical MRI (CryoProbe™, Bruker
Biospin MRI GmbH, Ettlingen, Germany). The RF coil head
(CryoProbe; Figure 1A left) is installed at the center of the
magnet bore. In this type, a set of torque rods (Figure 1A center)
are fitted to the RF probe to allow its tuning and matching
from the rear end of the MR system. The preamplifier and the
interconnection between preamplifier and CryoProbe are also
cryogenically cooled (Figure 1A right). Positioning of the mouse
underneath the CryoProbe is facilitated by a dedicated animal
cradle (Figure 1B top), which features a warm water heated floor,
nose cone with tooth bar and anesthetic gas outlet, ear bars for
head fixation, and spacers to adjust the z-axis position of the
cradle, as well as a lever system to permit lifting the cradle closer
to the CryoProbe once both are fully inserted and the mouse is
located below the RF coil (Figure 1B bottom).
Since the introduction of the first cryogenic MRI RF coil
the range of CryoProbes is steadily expanding. The initial
mouse brain quadrature transmit/receive MRI CryoProbes (for
FIGURE 1 | Hardware components and setup of MRI with cryogenic
radiofrequency coil technology (9.4 T MRI system 94/20 Biospec with
400MHz Quadrature TxRx CryoProbe, Bruker Biospin MRI GmbH,
Ettlingen, Germany; some parts not shown). (A) left: RF coil head
(CryoProbe); center: tuning/matching unit that is attached to the rear of the
CryoProbe when installed in the scanner; right: view of the rear of the magnet
with the CryoProbe and tuning/matching unit inserted into the magnet bore,
which are connected to the cryogenic preamplifier visible on the right hand
side. (B) top: cradle tailored to the CryoProbe, incorporating a warm water
based floor heating, nose cone with tooth bar (black), and outlet of anesthetic
gas, ear bars (black) for fixation of the mouse head, spacers (beige) to adjust
the z-axis position of the cradle underneath the CryoProbe, a lever system to
permit lifting the cradle slightly upwards closer to the CryoProbe once the
cradle has been fully inserted and the mouse is located below the CryoProbe;
bottom left and right: front of the cradle with a mouse set up for MRI, showing
the muzzle of the mouse in the nose cone, the ear bars fixing the head (see
view from above in right panel) and a rectal temperature probe (yellow) to
monitor core body temperature.
4.7–15.2 T MR systems) are now-a-days complemented by four-
channel array receive-only CryoProbes (for 7.0 and 9.4 T MR
systems), four-channel array CryoProbes for rats, and mouse X-
nuclei CryoProbes (for 9.4 T; e.g., 13C, Sack et al., 2014). The
latter are used in conjunction with a built-in room temperature
1H RF coil for decoupling and acquisition of anatomical
reference images. Finally, the receive-only CryoProbes allow
for the use of a room temperature volume resonator for RF
excitation, which improves transmission field (B+1 ) homogeneity.
Characteristics of Cryogenic RF Surface
Coils—The Pros and Cons
Cryogenic cooling of the RF coil and preamplifier more than
doubles the SNR compared with an equivalent RT coil setup.
In vivo mouse studies revealed typical SNR gains of 2.5–2.8
in the brain (Figure 2; Baltes et al., 2009, 2011; Junge, 2012),
3.0–5.0 in the heart (Wagenhaus et al., 2012), and 3.0–3.5 for 13C
spectroscopy in the brain (Sack et al., 2014). These examples of
sensitivity enhancements obtained for 400MHz (9.4 T) may only
serve as a basic reference because the SNR gain depends on the
frequency (see equation for SNR and Ratering et al., 2008) and the
choice of RT coil against which the performance of the CryoProbe
is benchmarked.
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In practical terms, a 100% SNR gain by use of a CryoProbe
is substantial enough to facilitate an improvement in spatial
resolution from e.g., (100 × 100)µm2 to (71 × 71)µm2 by
reducing the FOV. Maintaining the same FOV and acquisition
time the spatial resolution can be improved to (63× 63)µm2, as
a result of increasing the matrix size (by 58%) combined with a
reduction in the number of averages (by 36%). Alternatively an
acquisition time reduction by 75% could be attained with this
SNR gain via reducing the number of averages.
An SNR gain of 100% is equivalent to significantly increasing
the magnet field strength, which is not only more cost
intensive, but also comes along with challenges such as increased
susceptibility artifacts, disadvantageous relaxation time changes,
extra constraints for RF coil design at higher frequencies due
to wave length shortening and adverse effects for physiological
signals due to the interference with the magnetic field.
A surface coil design CryoProbe is essential to position the coil
as close as possible to the object under investigation, to conform
FIGURE 2 | Mouse brain gradient-echo images acquired at 9.4 T with a
RT receive-only RF coil (A) and a transmit/receive quadrature
CryoProbe (B). The overall SNR gain for the delineated brain region of interest
was 2.8. From Junge (2012), by permission of John Wiley & Sons Limited.
the coil geometry to the target anatomy, to keep coil size small
and remain within the coil noise dominated regime. Although
beneficial for signal sensitivity, an inherent limitation of surface
coils is an inhomogeneous distribution in both the transmit
RF field (B+1 ) and receive sensitivity profile (B
−
1 ). Figure 3
demonstrates the depth dependence of SNR for a spin-echo
imaging protocol. SNR is greatly enhanced by the CryoProbe,
but only within a certain range of depth, here approximately 2–
8mm from the surface of the coil. The receive sensitivity profile
of the surface RF coil reduces the ability to detect RF signals from
locations very close to as well as far away from the RF coil. These
variations might be a result of a transmit RF field inhomogeneity
of the coil which then translates into a variation in flip angle
across the field of view, thereby impacting on the signal intensity
and T1 image contrast. This applies to flip angles of excitation
pulses as well as any other RF pulses, such as refocussing RF
pulses with the exception of adiabatic pulses. Over a typical
field of view of 6–8mm (perpendicular to RF coil surface) the
relative B1 that is proportional to the flip angle can vary by
up to a factor of 2 (Figure 4; Baltes et al., 2009; Wagenhaus
et al., 2012). In gradient-echo images this variability may often
go unnoticed. However, in spin-echo images, large deviations
from the 90◦ excitation pulses and the 180◦ refocusing pulses
will eventually lead to inevitable signal losses. Transmit/receive
surface coils like most of the CryoProbes require RF power
adjustment on a coronal slice (rather than the standard axial
slice) which must be carefully positioned to achieve sufficient RF
power at larger depths while avoiding signal loss close to the RF
coil in spin-echo acquisitions due to too much RF power. B+1
inhomogeneity can be largely avoided with the recently available
receive-only CryoProbes, which make use of an additional RT
volume resonator for RF transmission.
In conclusion, various factors play a role in determining the
actual SNR gain, including magnet field strength, MR nucleus,
distance to the RF coil, RF power adjustment as well as the
MRI acquisition method. The typical improvement in SNR by
FIGURE 3 | SNR dependence on distance from RF coil surface (A) and corresponding ex vivo MR image of a mouse brain (B). Comparison of a 400MHz
transmit/receive linear CryoProbe with a RT quadrature receive-only RF coil. From Junge (2012), by permission of John Wiley & Sons Limited.
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FIGURE 4 | (A): illustration of the spatial variation of flip angle as relative
B+1 -map of a mouse heart in short axis view for a 400MHz transceiver
CryoProbe with surface coil design. (B): Plot of the B+1 profile along a line
crossing the heart (dotted line in B+1 -map). The B
+
1 decrease from anterior
(close to RF coil) to posterior is approximately 50% (factor of 2). From
Wagenhaus et al. (2012), by permission of Public Library of Science.
commercially-available CryoProbes can be expected to be a factor
of 2–3, which can be translated into more than 60% higher spatial
in-plane resolution or 75% shorter acquisition time.
NEUROVASCULAR APPLICATIONS
Animal Models of Multiple Sclerosis
The two key benefits of an SNR gain when using cryogenically-
cooled coils—namely reduced scan time and/or increased image
detail—are fundamental for studying dynamic pathological
processes in animal models of disease. In several pathological
conditions, especially those related to inflammation and vascular
remodeling, an important challenge is to differentiate between
hemodynamic alterations, inflammation, and degenerative
processes during different stages of disease. Differentiating
between pathological processes is essential in chronic
neuroinflammatory conditions such as multiple sclerosis
(MS) that include an inflammatory, demyelinating and
neurodegenerative component. A differentiation between these
processes is necessary to make the right therapeutic decision and
follow the correct line of treatment for each individual patient
(Sinnecker et al., 2012a,b, 2013; Wuerfel et al., 2012; Kuchling
et al., 2014).
The histopathological hallmark of MS is the demyelinated
plaque, which is associated with perivascular and parenchymal
inflammatory cell infiltration and axonal injury (Kuhlmann
et al., 2008). MS plaques can occur throughout the CNS;
in periventricular and deep white matter, optic nerves and
tracts, cerebellar peduncles, brainstem, spinal cord, and also
in the gray matter (Sinnecker et al., 2012b). MRI is the most
sensitive test to detect and demonstrate MS lesions (Milo and
Miller, 2014): while active inflammation is associated with newly
appearing, hyperintense MS lesions on T2-weighted MRI and
enhancement on T1-weighted MRI after contrast agent (Barkhof
et al., 1997; Brück et al., 1997), neurodegeneration is associated
with hypointensities on T1-weighted images and indicates severe
tissue damage (Van Waesberghe et al., 1999).
An animal model that resembles MS pathology is the
experimental autoimmune encephalomyelitis (EAE). EAE can be
induced by immunizing different susceptible species of animals
with specific CNS antigen e.g., proteolipid protein (PLP) in SJL/J
mice. The EAE model has been indispensable for understanding
neuroinflammatory disease (Ransohoff, 2009) and for evaluating
the effectiveness of nascent therapeutic approaches for MS (Ben
Nun et al., 1981; Steinman and Zamvil, 2006; Ransohoff, 2012).
Similarly to MS, lesions that are hyperintense on T2-weighted
MRI are present in EAE brains and correspond to inflammation,
demyelination and neurodegeneration (Deboy et al., 2007).
Also similar to MS, EAE lesions are distributed in time and
space (Baxter, 2007), commonly in the brain stem, midbrain,
cerebellum and periventricular area (especially in non-human
primates) but also in spinal cord, corpus callosum and cerebral
gray matter in small rodents (Verhoye et al., 1996; Hart et al.,
1998; Boretius et al., 2006; Deboy et al., 2007; Wuerfel et al., 2007;
Waiczies et al., 2012).
Brain MR microscopy is an invaluable tool to visualize
succinct inflammatory patterns, even prior to neurological
disease in the EAE. The main strengths of cryogenically-cooled
coils to boost SNR and thereby provide high resolution MR
microscopy and/or reduced scan time are best appreciated in
animal models such as EAE that undergo highly dynamic disease
profiles. Apart from the established hyperintense lesions on T2-
weighted images (commonly in the cerebellum), focal hypo-
intense lesions were identified in the somatosensory cortex of
EAE mice, when using high spatial resolution T2
∗ and T2
MRI in association with the CryoProbe (Waiczies et al., 2012).
With the cryogenic system, an in plane resolution is as good
as (35 × 35)µm2 and complete coverage of the brain could
be achieved on both T2
∗ and T2-weighted imaging. With this
capacity clear punctate lesions in cerebral gray matter could be
revealed in association with intracortical vessels and distributing
into the corpus callosum (Waiczies et al., 2012). Thanks to the
spatial resolution facilitated by Cryoprobe technology the lesions
that were revealed in vivo by MR histology could be clearly
corroborated as inflammatory infiltrates with hematoxylin and
eosin histology (Figure 5).
To gain a comprehensive and longitudinal view of brain
inflammation, particularly during the early stages of EAE,
MR methods that increase SNR are advantageous not only to
increase detail via high resolved brain microscopic imaging but
also to reduce scan time. Highly resolved MR images of the
whole brain could be achieved in 11min with the CryoProbe
(Figure 5; Waiczies et al., 2012). By reducing scan time, the
number of measurements per individual animal can be increased
during progression of disease. Repeated MR measurements
are fundamental when making assessments regarding structural
changes relevant to the pathology; even macroscopic changes
(that do not require highly resolved MRI to be revealed) can be
easily revealed. As a result of the reduced scan time and repeated
measurements achievable by the CryoProbe, ventriculomegaly
prior to neurological symptoms was revealed in the EAE (Lepore
et al., 2013).
In the past few years animal models that simulate the
neurodegenerative and demyelinating components of MS have
been studied independently of the inflammatory component
(Ransohoff, 2012). For instance transgenic models involving
suicide genes that induce oligodendrogliopathy are powerful
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FIGURE 5 | Hypo-intense regions on microscopic MRI correspond to cellular infiltrates detected by histology. (A) Coronal T2* weighted imaging (T2*W)
using a multislice fast low angle shot (2D FLASH: TR/TE: 473/18ms, FA 40◦, matrix 512× 512) sequence with an in plane resolution of (35× 35)µm2, 22 slices of
500µm, acquisition time to image the whole mouse brain = 11min. (B) Cellular infiltrates in cerebral cortex; the overview of the H&E histology is overlaid with a
coronal slice (plate 41) from Paxinos and Franklin (2013), by permission of Elsevier. (C) Susceptibility weighted imaging (SWI) of T2*W scans using fully-automated
post-processing by ParaVision 5.1 (Bruker, Ettlingen, Germany). From Waiczies et al. (2012), by permission of Public Library of Science.
tools for studying non-inflammatory demyelination and
remyelination (Traka et al., 2010; Pohl et al., 2011). Using a
cryogenically-cooled RF coil, pronounced T2 hyperintensities
were revealed in brain stem and cerebellar structures of this
model (Figure 6A); these changes were accompanied with
a decreased magnetization transfer ratio (MTR; Figure 6B;
Mueggler et al., 2012). MTR reflects the exchange of
magnetization between pools of differently mobilized protons
(Wolff and Balaban, 1989), commonly a rather freely mobile pool
and a rather immobile pool associated with macromolecules,
such as in axonal membranes or myelin (Alonso-Ortiz
et al., 2015). MTR correlates significantly with the degree
of myelination as shown in postmortem tissue of MS patients
(Schmierer et al., 2004). The decline in MTR that was observed
in the oligodendrogliopathy model with the aid of the CryoProbe
(Figure 6B) could be corroborated with evidence of white matter
pathology upon histological analysis (Figure 6C; Mueggler et al.,
2012).
Animal Models of Cerebral Amyloid
Angiopathies
Neurodegenerative pathologies that involve cerebrovascular
dysfunction include the cerebral amyloid angiopathies (CAA);
these form a major part of the pathophysiology of Alzheimer’s
disease (AD; Biffi and Greenberg, 2011). Also in this field,
transgenic systems and high resolution MR imaging are
proving extremely valuable for investigating the role of vascular
dysfunction and amyloid deposition in the pathophysiology and
treatment of CAA and AD (Klohs et al., 2014). An important
role for MR methods is for them to capture vascular remodeling
as a result of hemodynamic alterations; this is important when
studying the outcome of CAA on vascular integrity and function
(Salat, 2014). The cerebral vascular tree can be assessed by
different magnetic resonance angiography (MRA) techniques.
The signal in time-of-flight (TOF)-MRA depends on the blood
flow and is useful for determining changes in the architecture
of major blood vessels as well as reduced blood flow in mouse
models of AD and CAA. When spatial resolution is limited,
the tissue surrounding vessels also contributes to the MR signal.
Originally TOF-MRA was limited to large cerebral vessels with
high flow rates; small vessels suffer from both spin-saturation
artifacts and partial volume effects and their edges are more
difficult to visualize (Lin et al., 1997). The application of a
cryogenically-cooled coil system to increase the resolution of
TOF-MRA is a key to improve the detection of smaller vessel
(Figure 7A) in order to help identification of pathologies related
to neurovascular disease. The enhanced spatial resolution per
unit time introduced by the cryogenic system is key to start
overcoming some of the partial volume effects that contribute
to loss of small vessel visualization. Using a spatial resolution of
(150×100× 100)µm3, flow disturbances at the level of the circle
of Willis could be observed in the major arteries of aged animals
containing the amyloid precursor protein (APP)23 transgene
using TOF-MRA (Beckmann et al., 2003). Administration of
superparamagnetic iron oxide (SPIO) particles in association
with signal attenuations on three-dimensional (3D) gradient-
echo MRI also revealed CAA-related microvascular lesions in
different transgenic mouse models of AD including APP23 even
at a spatial resolution of (109 × 133 × 300) µm3 (Beckmann
et al., 2011). Using a cryogenically-cooled coil system and a
spatial resolution of (60 × 60 × 61) µm3, contrast-enhanced
(CE) micro (µ)MRA identified age-dependent and CAA-related
remodeling of the cerebral microvasculature in arcAβ mice
(Klohs et al., 2012). These transgenic mice express human APP
and are characterized by strong CAA pathology (Merlini et al.,
2011). Using longer san times, CE-µMRA was performed at
even higher spatial resolutions of (31 × 31 × 93) µm3 and
vessels could be tracked far into the periphery (Figueiredo
et al., 2012). Contrast enhanced (CE)-µMRI is expected to
complement TOF-MRA (Klohs et al., 2012); after administration
of the iron oxide contrast agent, hypointensities not discernable
on the precontrast image become visible; these represent intact
blood vessels (Figure 7B). In this study, CE-µMRA in association
with a CryoProbe revealed a reduction in the density of the
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FIGURE 6 | MRI signature in a novel mouse model of genetically induced adult oligodendrocyte cell death. (A) Parasagittal, quantitative T2 maps at
baseline (day 2), and end stage (day 41) oligodendrogliopathy following tamoxifen-induced ablation of oligodendrocytes (+TAM) and controls (−TAM). (B) MTR maps
from representative animals before (−TAM) and after (+TAM) oligodendrocyte ablation at baseline (day 2) and end stage (day 41). MTR maps are color-coded for
percentage and superimposed on T2-weighted images (cerebellum and brainstem section at the level of −2.3mm relative to Bregma). (C) Magnifications of
Histological cerebellar sections from end stage diseased animal stained with Luxol-Nissl for myelin content. From Mueggler et al. (2012), by permission of Academic
Press.
microvasculature in the arcAβ mouse during advanced disease
state (Klohs et al., 2012).
Tumor Models
The summed-up advantages of the Cryoprobe are of significant
benefit to visualize the pathology of tumor disease as well as
assess the outcome of treatment options. One major drawback
of standard clinical tumor imaging is associated with limitations
in spatial resolution. This major limitation hinders an adequate
delineation of tumor tissue from the surrounding healthy tissue
prior to surgical tumor resection and results in the reported
brain shift during navigated neurosurgical procedures (Reinges
et al., 2004). A thorough delineation of tumor borders could be
recently achieved in an animal model of high grade glioma by
using a Cryoprobe for acquisition of MR images with an in-plane
spatial resolution of 51mm (Ku et al., 2013; Vinnakota et al.,
2013). In these studies tumor MR microscopy was employed
to determine the molecular mechanisms behind tumorgenesis
as a precursor to therapeutic studies directed toward identified
molecular targets.
Angiogenesis and neovascularization are histopathological
hallmarks of cancer (Welti et al., 2013). Molecular determinants
that pave these processes need to be targeted to overcome the
current limitation of standard treatment regimen in reaching
malignant gliomas (Agarwal et al., 2011). The tumor vasculature
is functionally and structurally irregular and anti-angiogenic
therapies aim to normalize this vascular irregularity (Jain, 2005).
MR methods measuring perfusion, permeability, and vessel size
has been a necessary tool, commonly requiring application of
different contrast agents to monitor tumor neovascularization
especially as a means of assessing antiangiogenic therapy
response (Zwick et al., 2009; Knutsson et al., 2010). Recently,
vessel architectural imaging (VAI) was introduced and exploited
to study tumor vessel caliber, hemodynamics, and relative oxygen
saturation and used as a determinant of vessel type and function,
especially for therapy response, in glioma patients (Emblem
et al., 2013). Vessel size imaging (VSI) and DCE-MRI produce
complementary information about the tumor vasculature but
need to be performed separately due to the interaction between
contrast agents regarding magnetization (Beaumont et al., 2009;
Zwick et al., 2009). Recently, a cryogenically-cooled RF coil
system was used to combine VSI and DCE-MRI in a glioma
mouse model; a single shot gradient echo spin echo (GE-
SE) sequence was combined with echo-planar imaging (EPI)
and one contrast agent was used (Kording et al., 2014). The
superior SNR of the cryogenically-cooled coil that made an
increase in the receiver bandwidth possible, in combination with
careful shimming routines, ascertained that segmentation and
geometry between T2 maps, ADC maps, GE and SE echo planar
images (EPI) was not severely distorted (Kording et al., 2014).
In this study the distribution of vessel size was shown to be
larger in untreated glioma mice when compared to glioma mice
treated with anti-VEGF antibody (bevacizumab) (Kording et al.,
2014).
Blood Oxygenation Level Dependent
(BOLD) Functional MRI
With the increase of SNR in small animal MRI it has become
increasingly rewarding to advance upon investigations related
to central nervous processing. Functional MRI (fMRI) in mice
is a crucial tool to characterize transgenic mouse models of
human cerebral pathologies and determine the outcome of
therapies on the function of large-scale brain circuits. Functional
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FIGURE 7 | Visualization of vascular structures using cryogenically cooled RF coil technology to provide high resolution time-of-flight (TOF)-MRA and
spin dephasing following intravascular iron oxide contrast agent. (A) High-resolution 3D TOF-MRA (axial and horizontal view) of the intracranial and extracranial
vasculature of a 2-month-old wild type control mouse using a gradient echo sequence with flow compensation acquired at 9.4 T using the CryoProbe (TR = 30ms,
TE = 5.9ms, FOV = (30× 15 × 15) mm3, 512× 256 × 256, isotropic resolution = 59µm3. From Supplementary Data in Waiczies et al. (2012), by permission of
Public Library of Science. (B) Contrast-enhanced cerebral MRA of a 24-month-old wt mouse and an age-matched arcAβ mouse before and after administration of a
superparamagnetic iron oxide contrast agent. Images were acquired using a 3D FLASH sequence [TR = 150ms, TE = 2.9ms, FA = 20◦, FOV = (15× 12 × 2.2)
mm3, spatial resolution of (60× 60 × 61) mm3]. Difference images were obtained by subtraction of postcontrast image from precontrast image. The arrows point to
focal hypointense areas that are present before administration of the contrast agent. Scale bar: 1mm. From Klohs et al. (2012), by permission of Elsevier.
MRI takes advantage of neurovascular coupling as surrogate
of neuronal activity. Established measuring techniques track
local temporal changes in either blood flow, blood volume or
blood oxygenation—all shown as positively correlated with firing
rates of adjacent neuronal cell populations (Kim and Ogawa,
2012). Most common techniques in human fMRI make use of
the blood oxygenation level-dependent (BOLD) effect. Due to
different magnetic properties of oxygenated and deoxygenated
hemoglobin temporal changes in local field homogeneity can be
detected by T2
∗ weighted MR techniques. Single shot gradient
echo based echo planar imaging (GE-EPI) is commonly applied
to meet the requirements on BOLD signal sensitivity and high
temporal resolution.
To gain sufficient SNR at short acquisition times of 1–
8 s comes at the cost of spatial resolution limits in mouse
fMRI. At (ultra)high magnetic fields partial brain volumes are
commonly acquired with in plane resolutions of about 190–260
microns and a slice thickness of 500µm (Adamczak et al., 2010;
Baltes et al., 2011; Bosshard et al., 2012; Nasrallah et al., 2014;
Schroeter et al., 2014). At these voxel sizes GE-EPI is prone
to severe image distortions induced by macroscopic magnetic
field inhomogeneities, which increase with field strength. Mostly
affected regions are air-tissue boundaries (interfaces of bone,
tissue, and air). Gaining SNR by using systems with B0 ≥ 11.7
T further increases EPI image distortions (Adamczak et al.,
2010). Improving upon SNR by utilizing a CryoProbe permits
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preserving MR signal in imperiled brain regions. The CryoProbe
was shown to achieve a three-fold increase in SNR for GE-EPI
at 9.4 T compared to a conventional RT surface coil (Baltes et al.,
2011). Leveraging on the sensitivity gain of a cryogenically cooled
RF coil permits increases in receiver bandwidth, which facilitates
inter-echo time shortening in EPI. This results in an increase in
the bandwidth along the phase encoding direction which allows
for reduction in EPI image distortion (Figure 8A).
Functional brain mapping surveys voxel-wise signal changes
over time series of acquired image volumes. Signal and image
consistency can be significantly impaired by physical (thermal
noise, gradient heating) and physiological noise (cardiac,
respiration, vascular oscillations). For mouse fMRI physiological
noise is particularly relevant: due to the small body size inner
organs like heart and lungs are in close proximity to the receiving
RF head coil. Physiological noise (e.g., respiratory induced
periodic changes in B0 field homogeneity) gets amplified with
higher field strengths. Temporal SNR (tSNR) considers physical
and physiological fluctuations over time making it an important
measure for fMRI data quality. Baltes and colleagues reported
a 1 to 3-fold increase in tSNR with the CryoProbe over a
conventional RT mouse head coil at 9.4 T (Baltes et al., 2011).
Somatosensory studies using the CryoProbe revealed most
significant BOLD signal magnitudes in mouse fMRI with
external stimuli (Bosshard et al., 2010, 2012, 2015; Baltes et al.,
2011; Mueggler et al., 2011; Schroeter et al., 2014). Signal
intensity changes of up to 3.5% were observed in the primary
somatosensory cortex for electro-stimulation (Figures 8A,B;
Bosshard et al., 2010, 2012; Baltes et al., 2011; Schroeter et al.,
2014) and moderate noxious heat stimulation (Bosshard et al.,
2015) of the murine paw under isoflurane anesthesia. In murine
fMRI studies investigating somatosensation and pain commonly
anesthesia is applied for ethical and practical reasons (Borsook
and Becerra, 2011). Under these conditions BOLD magnitude
strongly depends on the applied anesthetic protocol and control
of physiological parameters (Schroeter et al., 2014). This makes
it somewhat difficult to compare fMRI data obtained with a
CryoProbe setup to other somatosensory mouse fMRI studies
using conventional room temperature RF coils.
A direct comparison of maximum BOLD signal changes
during electrostimulation of the murine forepaw using the
CryoProbe compared to a conventional RF mouse head coil was
conducted by Baltes et al. (2011). In this study scalp temperature
was found to be an important factor influencing the BOLD
signal magnitude. To ensure physiological temperatures at the
surface of the CryoProbe it features a thermal shield, which can
be adjusted in a certain temperature range. An internal heater
generates a thermal gradient along the ceramic surface. The
shield heating can be adjusted to result in the desired temperature
at the scalp-coil interface. In anesthetized mice reduced scalp
temperatures promote vasoconstrictive effects ascertained by
reduced baseline perfusion (Baltes et al., 2011). Higher SNR
FIGURE 8 | Blood oxygenation level-dependent (BOLD) fMRI significance maps (upper panel) and signal intensity time courses (lower panel) in mice
for electrical stimulation of the forepaw during isoflurane anesthesia (1%) and mechanical ventilation. (A) Upper panel shows BOLD significance maps
(upper row) for time series acquired using the CryoProbe revealing significant voxel clusters in primary somatosensory cortex (S1) and thalamic nuclei (TN) at 1.5mA
(p < 0.0001). Intensity corresponds to the number of animals displaying a significant BOLD signal. GE-EPI images (lower row) reveal only slight distortions. Lower
panel shows signal intensity changes over time for significant voxel clusters in S1 during stimulation at 0.5, 1.0, 1.5, and 2.0mA. Stimulus periods shaded in gray.
From Bosshard et al. (2010), by permission of Wolters Kluwer Health, Inc. (B) Comparison of mouse fMRI data for significant voxel clusters in S1 acquired using a
room temperature (RT) radiofrequency mouse head coil and the CryoCoil at different thermal shield temperatures. From Baltes et al. (2011), by permission of John
Wiley & Sons Limited.
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is expected to aid BOLD signal detection but should not alter
the BOLD effect itself. At physiological temperatures (Tscalp
of approx. 33.5◦C) maximum BOLD magnitude was found
to be similar for the CryoProbe and conventional RF mouse
head coil during electrostimulation of the forepaw (Figure 8B).
Mild cerebral hypothermia (Tshield = 27◦C) was shown to
significantly boost BOLD signal magnitude whereas severe
hypothermia (Tshield = 20◦C) decreased BOLD signal intensity,
most likely due to impairments in physiological processes. The
temporal noise for baseline measurements was significantly
reduced for the CryoProbe for all thermal shield temperatures
up to factor 2 compared to conventional RF mouse head coil
(Baltes et al., 2011). Therefore, the CryoProbe provides higher
BOLD signal sensitivity and might be capable to detect smaller
neurovascular changes. The possibility to adjust its surface
temperature permits to sustain more physiological thermal
conditions in anesthetized mice.
CARDIOVASCULAR APPLICATIONS
In Vivo Assessment of Cardiac Morphology
and Function
Realizing that cardiovascular disease (CVD) is one of the
leading causes of death (Heidenreich et al., 2011), research in
pathologies related to heart function remain at the forefront
of academia and pharmaceutical industry. For phenotyping of
disease models (e.g., myocardial infarction or hypertension-
induced myocardial injury/remodeling), as well as assessment
of gender effects, evaluation of novel therapeutics and long-
term follow-up studies non-invasive in vivo imaging of the heart
is conceptually appealing. Cardiovascular magnetic resonance
(CMR) is widely used in preclinical studies, the workhorse
being an assessment of cardiac morphology and function. For a
comprehensive and up-to-date review of CMR in small rodents
please refer to Bakermans et al. (2015).
A highly reproducible quantitative assessment of cardiac
morphology and function by CMR demands excellent spatial and
temporal resolution. Both come at the cost of SNR loss, which
can only be partially compensated for by increasingmeasurement
time. Together with the small size of the mouse heart and
its rapid motion (typical heart rates are 400–600 beats per
minute) these SNR limitations pose serious challenges to CMR
in mice. For cardiac chamber quantification and left ventricular
function assessment an excellent delineation of myocardial
borders, high ventricular blood-to-myocardium contrast and full
coverage of the cardiac cycle with high temporal resolution are
required. Furthermore, a complete coverage of the entire heart
with a sufficiently high spatial resolution to facilitate reliable
segmentation of the endo- and epicardial borders is crucial.
Current experimental CMR of mice uses dedicated birdcage
volume RF coils or surface RF coil arrays with the geometry
adjusted to the anatomy of the mice (Epstein, 2007; Heijman
et al., 2007; Hiba et al., 2007; Young et al., 2009; Ratering et al.,
2010; Schneider, 2011; Schneider et al., 2011) and affords images
with a typical in-plane spatial resolution of 100–200µm, heart
coverage of 6–13 slices of 1.0mm thickness and measurement
of 10–20 cardiac phases (Epstein, 2007; Heijman et al., 2007,
2008; Hiba et al., 2007; Sosnovik et al., 2007; Young et al.,
2009; Ratering et al., 2010; Bovens et al., 2011; Schneider,
2011; Schneider et al., 2011). Although providing acceptable
image quality for the quantitative assessment of the left ventricle
(LV), further improvement in image quality is highly desirable,
particularly for the assessment of the right ventricle (RV).
To meet this goal, enhancements in the spatial resolution are
essential, which in turn build upon SNR improvements.
An average gain in SNR of 3.6 in murine cardiac MRI
was achieved when comparing a CryoProbe at 9.4 T with a
conventional room temperature RF coil setup (receive-only four-
element mouse heart surface array RF coil in combination
with a volume resonator for transmission (Wagenhaus et al.,
2012). The SNR gain ranged 3.0–5.0 within the myocardium and
could be translated into higher spatial resolution imaging. The
highly detailed anatomical images derived from the CryoProbe
acquisitions provided significantly improved myocardial border
sharpness vs. the RT-coil acquisitions as illustrated in Figure 9A.
Hard evidence for the benefit of the enhanced image quality
was the improved reproducibility of the quantitative morphology
and function assessment. Using the CryoProbe, intraobserver,
and interobserver variability were smaller for almost all cardiac
function parameters. For instance intraobserver variability in
end-diastolic mass (EDM), end-diastolic volume (EDV), and
end-systolic volume (ESV) were reduced on average by 59 and
66% for the left and right ventricle, respectively. The practical
advantage is two-fold. An increased sensitivity will allow an
earlier detection of pathological changes as well as a more
thorough assessment of therapeutic effects. A smaller statistical
variability within experimental groups allows for a significant
reduction in animal group size.
Currently available cryogenic RF technology comes along with
some challenges for performing CMR. The CryoProbe cannot
easily be placed onto any anatomical region of interest since it
must be installed inside the magnet bore. Instead, the animal is
placed underneath the surface RF coil using a dedicated cradle.
This set-up is tailored and well-suited for mouse brain MRI. To
use it for CMR requires a special supine positioning of themouse.
Training and practice is necessary to position the heart correctly
within the field of view of the CryoProbe. The supine position
alters the shape of the RV (see short-axis view in Figure 9A and
long-axis view in Wagenhaus et al., 2012) but does not impact
on the functional parameters (Wagenhaus et al., 2012). In some
animals the supine position is accompanied by a difference in
motion of the septum, which continues throughout diastole and
results in blurring of the endocardial borders of the septum.
Inherent to surface coils is a decrease in signal-amplitude with
increasing distance (as explained above). Hence the CryoProbe
setup—just like the conventional RT surface RF coil setup—
displays a spatial variation in SNR across the myocardial
segments of a short axis view (Figure 9B), which can be explained
with the proximity to the surface coil. Inhomogeneity on the
RF transmit side (B+1 ) is usually of little concern for gradient-
echo based protocols such as the CINE FLASH commonly used
for assessment of cardiac morphology and function (Figure 9A;
Wagenhaus et al., 2012). Yet for techniques in which an exact
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FIGURE 9 | (A) Comparison of end-diastole short axis views acquired using a spatial resolution of (69× 115 × 800)µm3. Myocardial border delineation and depiction
of anatomic details for left ventricular papillary muscles and right ventricular trabeculae is enhanced in the CryoProbe (CP) image compared to the room temperature
(RT) coil image. (B) Bar plot of mean left ventricular myocardium SNR measured in images acquired with the CryoProbe (gray bars) or RT RF coil (white bars) in the
different segments of a six-segment model. The segments were numbered clockwise, starting at the inferoseptal segment. The region closest to the coil (segment 3)
showed the highest SNR, and SNR decreased with distance from the coil. From Wagenhaus et al. (2012), by permission of Public Library of Science.
flip angle is crucial—such as saturation based T1-weighted
gadolinium-enhanced first pass bolus perfusion studies (Utz
et al., 2007, 2008) or inversion recovery prepared T1-mapping
for detection of fibrosis or characterization of myocardial
tissue (Messroghli et al., 2003)—B+1 inhomogeneity may be
an unfavorable characteristic of the CryoProbe. Such cardiac
applications can benefit from using a volume resonator for
transmission in conjunction with the state-of-the-art receive-
only CryoProbe.
In conclusion, cryogenically cooled RF coils represent a
valuable means of enhancing the image quality in in-vivo CMR
of mice. They permit high spatial resolution CINE imaging
of the mouse heart with excellent SNR, which measurably
improves the reproducibility of quantitative cardiac morphology
and function assessment. This is important since segmentation of
themyocardium is challenging and prone to introduce significant
data variability.
Ex Vivo MR Microscopy of the Rodent
Heart
MRmicroscopy is a powerful tool to get an insight into the micro
architecture of myocardial tissue and provides results similar to
histology in a non-invasive matter. High spatial resolution and
an appropriate organ coverage are both essential. Quantitative
techniques like T2
∗ mapping, diffusion tensor imaging (DTI) or
quantitative susceptibility mapping (QSM) can complement the
information provided from common MR contrasts and allow
intersubject assessment. DTI or QSM require 3D datasets with
high isotropic resolution. Combining the requirements of high
resolution MR microscopy with large volume or whole heart
spatial coverage already puts a strain on balancing SNR with
scan time. T2
∗ weighting and diffusion weighting, as needed
for DTI or QSM, are also factors that inherently reduce SNR:
Sufficient initial SNR is needed, to ensure adequate signal even at
long TEs or for strong diffusion weighting. Thus, several features
of quantitative myocardial MR microscopy constrain SNR and
bring about the need for lengthy scan times to compensate for
SNR losses. Even in ex vivo scans where acquisition time is
by far not as limited as in in vivo scans, counteracting SNR
losses by averaging can easily result in days of acquisition
time. Unfortunately, this condition is not feasible even in an
ex vivo setting. Using a cryogenic RF probe helps to balance
the competing constraints of high spatial resolution, high spatial
coverage and sufficient T2
∗ or diffusion weighting in acceptable
acquisition times at ample signal to noise.
Figure 10 shows examples for high resolution T2
∗ weighted
3D MR microscopy of the fixed ex vivo rat heart at 9.4 T.
These short and long axis views of the heart were derived from
acquisitions using a conventional room temperature birdcage
RF coil and a cryogenic surface RF coil (Huelnhagen et al.,
2014; Peper et al., 2015). Signal magnitude and corresponding
T2
∗ maps derived from fitting the signal decay over 5 echo
times are shown. Sub-millimeter structures, which can clearly
be delineated in images obtained with the CryoProbe, are
dominated by noise in the images acquired using the room
temperature RF coil. With identical sequence and protocol
settings and equal acquisition times approximately a five-fold
mean SNR enhancement was achieved in this example when
using the cryogenic RF probe. Attributing the SNR increase in
this case solely to the fact that a cryogenic probe has been used
would not be entirely appropriate since moving from a volume
to a surface RF resonator usually goes along with an SNR gain
at least in regions close to the RF coil. Notwithstanding this
limitation it is fair to state that high SNR level images obtained
with the cryogenic RF probe cannot be accomplished with the
room temperature probe using the same imaging protocol and
scan times. The SNR and signal uniformity implications of the
limited field of view and B1 gradient of the cryogenic surface
RF coil can be recognized from the axial images. These non-
uniformities can be corrected but might constitute a challenge
for sample sizes not matching the coil geometry. If the sample
size however, is in the range of the field of view specifications of
the cryogenic RF surface coil, high resolution MR microscopy
provides images that are comparable with histology, earning
heart MR microscopy the moniker of cardiac MR histology.
Figure 11 illustrates an example of a fixed ex-vivo mouse heart
scanned in 3D with an isotropic spatial resolution of 55µm3
using a cryogenic surface RF coil at 9.4 T (Peper et al., 2015).
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FIGURE 10 | Axial (top) and coronal (center) views of high resolution T2* weighted 3D MR microscopy images (A) and corresponding T2* maps (B) of
the fixed ex vivo rat heart acquired using a room temperature volume RF resonator and a cryogenic surface RF probe at 9.4 T [3D multi echo gradient
echo technique, TR = 19ms, TE = 2.14–13.54ms, TE spacing 2.85ms, spatial resolution = (94× 94 × 94)µm3, FOV = (20× 15 × 15) mm2, acquisition
time 12.7 h]. Bottom: Detail views of areas marked by colored rectangles. Dashed white lines mark the position of the slices. Data from Huelnhagen et al. (2014);
Peper et al. (2015).
FIGURE 11 | Sagittal slices of high resolution 3D MR microscopy images of the fixed ex vivo mouse heart acquired at 9.4 T using a cryogenic RF
probe: (A) signal magnitude image, TE = 2.14ms (B) principal diffusion direction derived from DTI (C) T2* map and (D) quantitative susceptibility map.
Acquisition parameters: 3D multi echo GRE: TR = 250ms, TE = 2.14–44.96ms, TE spacing 2.85ms, spatial resolution = (55× 55 × 55) µm3, FOV = (10× 10 × 10)
mm3, TA = 13.7 h; DTI-EPI: TR = 1000ms, TE = 22.84ms, spatial resolution = (156× 156 × 156) µm3, FOV = (10× 10 × 10) mm3, b = 2000 s/mm2, 30 directions,
TA = 17 h. Data from Peper et al. (2015).
Making use of the SNR gain of the cryogenic RF probe, despite
the very high spatial resolution, an SNR of more than 60 was
achieved for the first echo (TE = 2.14ms). Even for long echo
times SNR obtained with the cryogenic RF coil is appropriate to
accommodate accurate T2
∗ mapping.
To summarize, MRmicroscopy of the heart with a high spatial
coverage heavily benefits from using cryogenic RF resonators
especially when contrast weighting is required, as in parametric
mapping or diffusion weighted applications. The benefit is
paramount during the characterization and phenotyping of
animal models of cardiac disease as it provides a valuable means
of getting a better understanding of myocardial microstructure
and myocardial remodeling. The value of such improvements
are in positive alignment with human MR studies at ultrahigh
magnetic fields (VonKnobelsdorff-Brenkenhoff et al., 2010, 2013;
Dieringer et al., 2011; Thalhammer et al., 2012; Winter et al.,
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2012; Graessl et al., 2014) which strive for a relative spatial
resolution (number of pixel per cardiac anatomy) approaching
that of experimental MRI in small rodents with the ultimate
goal to provide imaging means for diagnostics and for guiding
treatment decisions in cardiovascular and metabolic diseases
(Niendorf et al., 2010, 2013, 2015a).
RENAL APPLICATIONS
Ex Vivo MR Microscopy of the Rodent
Kidney
Hurlston et al. (1999) ventured into an early exploration
of ex vivo mouse kidney MR microscopy; their prototype
HTS Helmholtz RF probe provided a seven-fold gain in SNR
compared to a room temperature Helmholtz RF coil. Using the
superconducting coil, the feasibility of renal MR microscopy was
demonstrated at 9.4 T with 17µm in-plane resolution in little
more than an hour scan time (Figure 12; 3D spin-echo, (17× 17
× 136)µm3 spatial resolution).
The sensitivity gain of cryogenic RF coil technology
can be put to good use for renal MR microscopy of
glomeruli, the microscopic filtering units of the kidney.
Glomerular size and number is thought to be linked to several
renal and cardiovascular diseases (Hoy et al., 2008). While
established techniques for measuring/counting glomeruli rely on
extrapolations made from measurements/counts within small
samples (Beeman et al., 2011), a total and direct quantification
can be made by renal MR microscopy (Beeman et al., 2011;
Heilmann et al., 2012). By exploiting the sensitivity boost of
a CryoProbe, Heilmann et al. (2012) were able to quantify
glomerular number and size in ferritin labeled rat kidneys ex vivo
with a scan of less than 5 h duration. Automatic segmentation
of 3D GRE images with (35 × 35 × 35)µm3 spatial resolution
yielded glomerular diameters (mean ± SD = 109 ± 4.9µm) and
counts (mean ± SD = 32,785 ± 3117) with low intra-subject
variability in one-seventh of the time required for traditional
stereology.
In Vivo Structural and Functional Renal
MRI
To date the potential for improving spatial resolution and
increasing temporal resolution by use of a CryoProbe for in vivo
renal MRI remains largely untapped. The boost in SNR can be
expected to be similar to that reported for cardiac applications,
FIGURE 12 | Early proof-of-concept for renal MR microscopy at 9.4 T
with 17µm in-plane resolution. (A) Room temperature Helmholtz RF coil.
(B) High-temperature superconducting Helmholtz RF probe. From Hurlston
et al. (1999) by permission of John Wiley & Sons Limited.
i.e., approximately three-fold (Wagenhaus et al., 2012). Organ
size and depth of location within the thorax/abdomen are
comparable. The same room temperature RF coils are typically
used for both applications, commonly a four-element saddle-
shaped receiver (RX) array in conjunction with a larger transmit
(TX) volume resonator. In vivo MRI of a mouse kidney is
perfectly feasible with a mouse CryoProbe (Xie et al., 2014;
Figure 13). However, imaging of both kidneys simultaneously
requires a much larger field of view than needed for a single
kidney or the heart. The rat CryoProbe may be an attractive
alternative as it provides a uniform signal intensity distribution
over a larger field of view than the mouse CryoProbe (Figure 14).
Objective signal and noise measurements will however still
be required since these coils were not originally designed for
matching the geometry of the mouse body and for optimized
kidney imaging.
The combination of high speed acquisition with almost
microscopic spatial resolution is of great interest also in other
areas of functional renal MRI, such as T2
∗ monitoring, as
surrogate for renal blood oxygenation. Parametric mapping
of T2
∗ with sub-minute temporal resolution is essential for
capturing the fast dynamic changes in renal hemodynamics
and oxygenation during acute ischemic events or physiological
test stimuli (Pohlmann et al., 2013b, 2014a). Comparison
with renal MR microscopy images (Xie et al., 2012; Niendorf
et al., 2015b) suggests that the limited spatial resolution of
current in vivo protocols used for monitoring T2
∗ masks some
of the underlying intra-layer heterogeneity of renal structure
and function. Higher spatial resolution for renal parametric
MRI, which puts a strain on SNR, is therefore warranted
especially in the mouse. Reduced oxygenation of intrarenal
blood can lead to an additional loss of signal, which can be
substantial in images acquired at larger echo times. Elucidating
ischemia/reperfusion (I/R) injury, a consequence of kidney
hypoperfusion or temporary interruption of blood flow—a
common cause of acute kidney injury (AKI)—requires fast
continuous T2
∗/T2 mapping throughout baseline, ischemia,
early reperfusion, and recovery (Pohlmann et al., 2013b) and
hence benefits from scan acceleration using parallel imaging
strategies. To this end, the SNR gain offered by a multi-
channel receive cryogenic RF coil array is instrumental for
compensating noise amplification inherent to parallel imaging
(Niendorf and Sodickson, 2006a,b, 2008). The speed gain is
of benefit in preclinical renal MRI studies where multiple
parameters are assessed by multiple modalities including (i)
quantitative physiological measurements such as renal perfusion
pressure, renal blood flow, local cortical and medullary tissue
pO2 and blood flux and, (ii) comprehensive MRI protocols with
tight spatio-temporal resolution constraints dictated by renal
(patho)physiology and the interleaving with the quantitative
physiological measurements (Pohlmann et al., 2014a). For
all these reasons, cryogenic RF coil technology holds great
potential for enabling non-invasive in vivo investigations into
renal hemodynamics and oxygenation with MRI. Conventional
methods for assessing renal hemodynamics and oxygenation
such as fiber-optical pO2 probes or ultrasonic flow probes
provide quantitative physiological data, but are invasive and the
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FIGURE 13 | CryoProbe application in fast DCE-MRI of the mouse kidney (Xie et al., 2014). T1-weighted renal images (top) are shown for 7 out of 390
acquired time points. Signal time-courses for small regions-of-interest in renal cortex (CO), outer stripe (OS), and inner stripe (IS) of the outer medulla, and the inner
medulla (IM) illustrate the excellent SNR. The derived parameters time-to-peak and decay constant reflect the inter-layer functional differences. From Xie et al. (2014)
by permission of John Wiley & Sons Limited.
FIGURE 14 | Comparison between an axial view of the mouse kidneys using a mouse CryoProbe and a rat CryoProbe at 9.4 Tesla. The mouse
CryoProbe only permits imaging of one kidney due to the limited field of view (A). Using the rat CryoProbe enables simultaneous imaging of both mouse kidneys with
a more homogenous signal intensity distribution (B: axial view, C: coronal view). Experimental details are: (A) FLASH, TR = 350ms, TE = 5.4ms, FOV = (30× 20)
mm2, resolution = (156× 208)µm2, slice thickness = 1000µm, scan time = 0.6min. (B) FLASH, TR = 120ms, TE = 2.9ms, FOV = (30× 30) mm2, resolution =
(136× 94)µm2, slice thickness = 500µm, scan time = 1.3min. (C) TurboRARE, TR = 750ms, TE = 24ms, FOV = (30× 30) mm2, resolution = (94× 94)µm2, slice
thickness = 500µm, scan time = 4.5min.
fiber probes enable measurements in pin-point locations only
(Arakelyan et al., 2013; Pohlmann et al., 2013a).
Assessing Renal Perfusion, Oxygenation,
or Inflammatory Cell Infiltration Using
Fluorine (19F) MRI
Renal tissue hypoxia and inflammatory mechanisms play
prominent roles in the pathophysiological chain of events that
lead to acute kidney injury and promotes progression from acute
injury to chronic kidney disease. Dependent on disease etiology,
the contribution and impact of inflammatory mechanisms may
vary (Chawla et al., 2014). Inflammatory processes, including
early responses dominated by the innate immune system as
well as later responses by the adaptive immune system, can
support repair and restoration of renal functions but may also
promote renal tissue injury and transition to chronic disease
(Bonventre and Yang, 2011; Kinsey and Okusa, 2014; Molitoris,
2014).
Acute kidney injury can also trigger a systemic immune
response that may lead to secondary dysfunction of organs such
as heart, brain, and lung (Grams and Rabb, 2012). Alternatively,
systemic immune diseases can have a crucial impact on
the kidney e.g., antineutrophil cytoplasmic antibody (ANCA)-
associated vasculitis often affects the kidneys leading to rapid-
progressive glomerulonephritis (Schreiber and Choi, 2015).
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Renal blood volume, blood oxygenation, and inflammatory
cell migration can be assessed and monitored using cutting-edge
19F MR techniques (Ruiz-Cabello et al., 2011; Hu et al., 2014).
MRI of x-nuclei suffers from an inherently low SNR due to
limited MR sensitivity (19F ≈ 1H) but also a low abundance of
nuclei in the tissue of interest. Indeed, 19F is virtually absent in the
living tissues of rodents and the 19F signal is created by injection
of exogenous 19F contrast agents. A commonly used variant of
such 19F agents is perfluorocarbon (PFC) (Ruiz-Cabello et al.,
2011), which can be used to label inflammatory cells in vivo
after systemic application (Waiczies et al., 2013) or track specific
immune cells in vivo after in vitro labeling (Ahrens et al., 2005;
Waiczies et al., 2011).
Systemic i.v. administration of 19F nanoparticles (droplet
emulsion) results in uptake and self-labeling by phagocytic
immune cells e.g., macrophages, neutrophils or dendritic
cells. Application of these nanoparticles to an ANCA-induced
glomerulonephritis model demonstrated a significant 19F MRI
signal in the kidney (in contrast to kidneys of control animals
that showed negligible signal). This method provides an in vivo
depiction of renal inflammatory cell dynamics (Figure 15;
Pohlmann et al., 2014b).
Yet, the rather low spatial resolution of (0.94 × 0.94 × 1.88)
mm3 and required acquisition time of almost an hour leave a lot
to be desired. Here the low SNR is a fundamental factor that is
restricting the capabilities of 19F MR in rodents. SNR negatively
correlates to the detection limit for 19F labeled cells. Applications
in which harvested immune cells are labeled in vitro and re-
applied to an animal have an even greater need for high sensitivity
because in this case the number of labeled cells in the region of
interest is much smaller (Waiczies et al., 2013).
Noteworthy for 19F MRI, a gain in SNR of 3.0–3.5 for the
13C CryoProbe (Sack et al., 2014) and 2.5 for the 1H CryoProbe
(Baltes et al., 2009) were reported at 9.4 T. Considering the
close proximity of 19F and 1H frequency, an SNR gain of at
least 2.5 will be expected for a 19F CryoProbe at 9.4 T, a gain
that would permit an enhanced spatio-temporal resolution of
preclinical 19F MRI and pave the way for better detection and
more efficient tracking of cellular therapies such as dendritic cells
that are used in a variety of cancers. With a technology that
provides better detection of cells, even in far reaching organs,
the best cell therapy solutions for pathologies such as recalcitrant
cancers can be determined more efficiently and swiftly. These
therapeutic solutions in combination with advanced clinical
imaging technologies can ultimately be translated to the clinic
and incorporated into personalized medicine.
OUTLOOK
The cryogenic RF coil technology has introduced significant
advancements to small animal MR image acquisition in different
areas of disease research. With the ever increasing clinical needs
and research explorations looming over the MR horizon, further
innovations in association with this technology are nevertheless
likely to be expected. The opportunity of increasing sensitivity
as well as spectral, spatial, and temporal resolution as a result
of increased SNR with the cryogenic RF coil technology opens
FIGURE 15 | (A) Coronal 19F images of a mouse with ANCA-induced
glomerulonephritis; 8 weeks after bone marrow transplantation showing
extensive renal inflammatory cell infiltration, particularly in the cortex in
comparison with a naïve mouse (B) showing a high signal in liver and spleen,
but none in the kidneys. The low SNR of room temperature RF technology
severely limits the spatial resolution achievable even at extended scan
durations of almost 1 h. L indicates liver, S indicates spleen, and yellow dot
lines depict kidneys. Data from Schreiber et al. (2013).
up more prospects for advancing evolving MR techniques in
spectroscopy (MRS), imaging (MRI), or spectroscopic imaging
(MRSI). MR methods for studying the detection and distribution
of metabolites containing proton (1H) and x-nuclei e.g., carbon
(13C), oxygen (17O), sodium (23Na), and phosphorous (31P) will
benefit immensely from the introduction of cryogenically-cooled
coils. In addition to the increased SNR, which is particularly
favorable for nuclei with a relatively low biological abundance
(e.g., 13C, 23Na, 31P), better spectral resolutions are expected
to reveal metabolites that have until now remained undetected,
keeping in mind that resolution comes at a cost in SNR. Another
evolving field that will benefit from cryogenically cooled RF coils
is functional MRS (fMRS), which when used in conjunction with
BOLD fMRI will be invaluable to study changes in resting and
activation states in the brain. MRSI employing high-speed echo-
planar encoding will also benefit from sensitivity gains to spatially
map multiple tissue metabolite signals in vivo.
A gain in sensitivity and resolution that can be delivered
by cryogenically cooled RF coils can be attained by increasing
magnetic field (B0) strengths, but the side effects and costs
associated with higher B0 are in such a case non-existent.
Challenging adverse effects of higher B0 (that can be eliminated
with cryogenic RF coil cooling at lower fields) include saturation-
related signal losses due to longer T1 relaxation times, shorter
echo time acquisitions to compensate for sensitivity losses due to
shorter T2 relaxation times and line broadening or off-resonant
effects due to B0 susceptibility effects. For small animal imaging,
cryogenically cooled RF coils would benefit from small cryogen-
liquid free magnets systems with variable field operation and
automatic field ramping. These MR systems can be operated
at magnetic field strengths of 1.5, 3.0, or 7.0 T and hence
provide opportunities for harmonizing basic with translational
research. The installation andmaintenance of suchMR systems is
affordable and thus ideal for preclinical research. Equipped with
one cryogenically cooled RF coil suchMR systems with cryogenic
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liquid-free magnets will be an invaluable technology for disease
phenotyping, multi-modal imaging as well as for spanning of
an assortment of x-nuclei for metabolic, molecular, and cellular
imaging.
The benefits of the cryogenically-cooled RF coil technologies
are in positive alignment with our human MR studies at
ultrahigh B0 fields, which strive for the spatial resolution used
in experimental small animal MRI, but necessitate complex
techniques (such as volume-selective higher-order B0 shimming
and phase correction strategies) to counterbalance the B0 adverse
effects. Considering the advantages of cryogenically cooled
RF coils and the expected immense application for human
studies a swift clinical translation is warranted. For starters,
tremendous sensitivity gains will be expected when using smaller
cryogenically cooled coils in association with higher B0; the
stronger magnetic coupling between small coil and sample is
attributed to higher signal sensitivities and the smaller volume
of tissue seen by smaller coils is attributed to lower noise. MR
applications that will particularly benefit from cryogenically-
cooled RF coil systems, particularly at UHF strengths, are
diffusion weighted imaging (DWI) methods employing stronger
diffusion-weighting (b-values > 2000 s/mm−2) in order to
demonstrate the biexponential decay of brain diffusion, and
better differentiate between different water compartments,
especially during ischaemic and other brain pathology (Norris
and Niendorf, 1995; Dijkhuizen et al., 1996; Niendorf et al.,
1996). Although higher b-values yield higher diffusion contrast,
lower SNR is expected on heavily diffusion-weighted images,
such that cryogenically-cooled coils will surely be invaluable
for this application. Alternatively, the SNR gain inherent to
cryogenically-cooled RF coils could be transferred into using
a larger range of diffusion weighting, which would be of
great benefit for in vivo explorations into the biophysics of
water diffusion in tissue (Niendorf et al., 1994; Norris et al.,
1994; Pyatigorskaya et al., 2014; Le Bihan and Iima, 2015)
but also for the study of intracellular compartmentation of
metabolites, with the implication feeding into neuroradiology,
neurology and related clinical disciplines (Najac et al., 2014).
Other foreseen human applications for cryogenically-cooled RF
coils will include anatomic micro-imaging of the skin. Pioneering
work undertaken with a HTS coil at 1.5 T recently demonstrated
a subnanoliter spatial resolution (80µm3) for human skin
MR microscopy (Laistler et al., 2015). Skin-sodium storage, as
a physiologically important regulatory mechanism for blood
pressure, volume regulation, and indeed survival, has recently
been rediscovered. This prompted the development of MRI
methods to assess sodium storage in humans with 23Na-MRI
at 3.0 Tesla (Kopp et al., 2012, 2013) and at 7.0 T; the latter
facilitating a spatial resolution across the skin of as good as
1mm in-plane (Linz et al., 2015). To this end, cryogenically
cooled RF technology indeed represents a powerful research tool
that can potentially help to unlock questions regarding Na+
balance and Na+ storage functions of skin with the ultimate
goal to provide imaging means for diagnostics and for guiding
treatment decisions in cardiovascular and metabolic diseases. It
is however envisioned that the benefits of cryogenically-cooled
coils for human application at ultrahigh fields will also go beyond
skin microimaging of sub-nanoliter voxels. The significance of
the cryogenic technology to advance upon current x-nuclei
MR methods for metabolic probing (Linz et al., 2015) and
pharmacological studies (Ji et al., 2015) is an area that will
definitely receive considerable attention in the coming years.
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